AN2 Therapeutics Inc (ANTX) concluded trading on Wednesday at a closing price of $1.30, with 5.52 million shares of worth about $7.18 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -38.68% during that period and on November 20, 2024 the price saw a gain of about 22.64%. Currently the company’s common shares owned by public are about 29.74M shares, out of which, 21.41M shares are available for trading.
Stock saw a price change of 28.71% in past 5 days and over the past one month there was a price change of 20.37%. Year-to-date (YTD), ANTX shares are showing a performance of -93.66% which decreased to -92.07% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.87 but also hit the highest price of $22.22 during that period. The average intraday trading volume for AN2 Therapeutics Inc shares is 376.74K. The stock is currently trading 20.43% above its 20-day simple moving average (SMA20), while that difference is up 22.26% for SMA50 and it goes to -44.36% lower than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
AN2 Therapeutics Inc (NASDAQ: ANTX) currently have 29.74M outstanding shares and institutions hold larger chunk of about 40.07% of that.
The stock has a current market capitalization of $38.84M and its 3Y-monthly beta is at -0.23. It has posted earnings per share of -$2.04 in the same period. It has Quick Ratio of 9.75 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for ANTX, volatility over the week remained 9.84% while standing at 4.67% over the month.
Stock’s fiscal year EPS is expected to rise by 37.08% while it is estimated to increase by 33.76% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Leerink Partners on August 09, 2024 offering a Market perform rating for the stock and assigned a target price range of between $5 and $1 to it. On July 03, 2024, Leerink Partners Upgrade their recommendations, while on April 02, 2024, JMP Securities Upgrade their ratings for the stock with a price target of $6. Stock get a Market perform rating from Leerink Partners on February 13, 2024.
